Autoimmune diseases — conditions in which the immune system attacks the body’s own tissues — affect approximately 8% of the global population and are increasing in prevalence. PFAS immune-disrupting effects may contribute to autoimmune disease development by dysregulating the balance between immune activation and self-tolerance.
PFAS Immune Dysregulation and Autoimmunity
A healthy immune system maintains a careful balance: it must be aggressive enough to neutralize pathogens and cancer cells, while tolerant enough to avoid attacking the body’s own tissues. PFAS disrupt this balance through effects on T regulatory cells (Tregs), which normally suppress autoimmune responses, and by promoting pro-inflammatory cytokine production that can trigger autoimmune activation.
PFAS-induced changes in B cell function may also contribute to autoimmunity by altering the production and specificity of antibodies. When B cells produce antibodies against self-antigens — driven partly by PFAS-related dysregulation — autoimmune tissue damage can result.
Lupus and PFAS Exposure
Systemic lupus erythematosus (SLE) is a complex autoimmune disease primarily affecting women. Research has found elevated PFAS levels in some lupus patient populations, and animal studies have shown that PFAS can accelerate lupus-like disease in genetically susceptible models. The connection between PFAS and lupus is biologically plausible given PFAS effects on immune signaling and the known importance of environmental triggers in lupus development.
Anti-nuclear antibodies (ANAs) — autoantibodies characteristic of lupus and other connective tissue diseases — have been found at higher levels in some studies of PFAS-exposed populations, suggesting that PFAS may promote the initial steps of autoimmune sensitization even before clinical disease develops.
Thyroid Autoimmunity
Hashimoto’s thyroiditis and Graves’ disease — both caused by autoimmune attack on the thyroid — may be particularly relevant to PFAS exposure given PFAS effects on thyroid function. Some studies have found elevated anti-thyroid antibodies in PFAS-exposed populations, suggesting that PFAS may contribute to thyroid autoimmunity specifically, in addition to the direct thyroid hormone effects discussed separately.
Inflammatory Bowel Disease
Crohn’s disease and ulcerative colitis — chronic inflammatory bowel diseases with autoimmune components — have been examined in relation to PFAS. Some epidemiological studies have found higher rates of inflammatory bowel disease in PFAS-contaminated communities, consistent with PFAS-induced gut immune dysregulation and disruption of intestinal barrier function.
Implications for Autoimmune Disease Management
For individuals with autoimmune diseases or strong family histories of autoimmune conditions, reducing PFAS exposure represents a potentially meaningful environmental modification. While PFAS cannot be the sole explanation for autoimmune disease development, eliminating major exposure sources through water filtration may help reduce the immune burden in susceptible individuals.